Clinical prognosis of hydronephrosis treated with urological intervention after radical hysterectomy for uterine cervical cancer: clinical study

Purpose: To review the clinical prognosis of hydronephrosis treated with urological intervention (HTUI) after radical hysterectomy (RH) for uterine cervical cancer. Materials and Methods: Thirty-six of 270 patients who underwent RH between January 2010 and December 2015 were included. The authors compared the prognostic factors for the resolution of hydronephrosis between resolution (n= 17) and non-resolution groups (n=19) after HTUI. Results: There were no significant differences in valuables between the two groups. Combined percutaneous nephrostomy and intraureteric stent was most frequently used as the first procedure (n=23). Age > 55.5 years and onset time of hydronephrosis after RH > 2.75 months showed poor prognosis for HTUI on receiver operating characteristic (ROC) curve. The rates of HTUI varied depending on each institution (0−14.4%). Conclusions: Old age and later onset of hydronephrosis could be the important prognostic factors for HTUI. The rate of HTUI depended on each institution and its surgical techniques.

Hydronephrosis; Cervical cancer; Radical hysterectomy; Intervention.

[1] Caelea M., John C.E.: “Cervical and vaginal cancer”. In: Berek J S. (ed). Berek & Novak’s Gynecology. 15th ed. Philadelphia, PA, Lippincott & Wilkins, 2007, 1325.

[2] Suprasert P., Euathrongchit J., Suriyachai P., Srisomboon J.: “Hydronephrosis after radical hysterectomy: a prospective study”. Asian Pac. J. Cancer Prev., 2009, 10, 375.

[3] Hazewinkel M.H., Gietelink L., van der Velden J., Burger M.P., Stoker J., Roovers J.P.: “Renal ultrasound to detect hydronephrosis: a need for routine imaging after radical hysterectomy?” Gynecol. Oncol., 2012, 124, 83.

[4] Ulmsten U.: “Obstruction of the upper urinary tract after treatment of carcinoma of the uterine cervix”. Acta Obstet. Gynecol. Scand.,1975, 54, 297.

[5] Larson D.M., Malone J.M. Jr, Copeland L.J., Gershenson D.M., Kline R.C., Stringer C.A.: “Ureteral assessment after radical hysterectomy”. Obstet. Gynecol., 1987, 9, 612.

[6] Tsurusaki T., Hoshino K., Igawa T., Koga S., Matsuya F., Yamashita S., et al.: “Clinical examination and therapies of hydronephrosis after radical hysterectomy”. Nihon Hinyokika Gakkai Zasshi, 1994, 85, 328.

[7] Kim C., Song Y.S., Kim H.H.: “The changes and natural progress of hydronephrosis following radical hysterectomy”. Korean Journal of Urology, 2002, 43, 1003.

[8] Paick S.H., Oh S.J., Song Y.S., Kim H.H.: “The natural history of hydronephrosis after radical hysterectomy with no intraoperatively recognizable injury to the ureter: a prospective study”. BJU Int., 2003, 92,748.

[9] Mittelstaedt CA: “Kidney”. In: Mittelstaedt C.A. (ed). General Ultrasound. New York: Churchill Livingstone, 2004, 833.

[10] Piver M.S., Rutledge F., Smith J.P.: “Five classes of extended hysterectomy for women with cervical cancer”. Obstet. Gynecol., 1974, 44, 265.

[11] Okabayashi H.: “Radical abdominal hysterectomy for cancer of the cervical uteri, modification of the Takayama operation”. Surg. Gynecol. Obstet., 1921, 33, 335.

[12] Fujii S., Takakura K., Matsumura N., Higuchi T., Yura S., Mandai M., et al.: “Precise anatomy of the vesico-uterine ligament for radical hysterectomy”. Gynecol. Oncol., 2007, 104, 186.

[13] Fujii S., Takakura K., Matsumura N., Higuchi T., Yura S., Mandai M., et al.: “Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy”. Gynecol. Oncol., 2007, 107, 4.

[14] Dornhöfer N., Höckel M.: “New developments in the surgical therapy of cervical carcinoma”. Ann. N. Y. Acad. Sci., 2008, 1138, 233.

[15] Chong G.O., Lee Y.H., Hong D.G., Cho Y.L., Park I.S., Lee Y.S.: “Robot versus laparoscopic nerve-sparing radical hysterectomy for cervical cancer: a comparison of the intraoperative and perioperative results of a single surgeon’s initial experience”. Int. J. Gynecol. Cancer, 2013, 23, 1145.

[16] Hwang J.H., Lim M.C., Joung J.Y., Seo S.S., Kang S., Seo H.K., et al.: “Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy”. Int. Urogynecol. J., 2012, 23, 1605.

[17] Roh J.W., Lee D.O., Suh D.H., Lim M.C., Seo S.S., Chung J., et al.: “Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial”. J. Gynecol. Oncol., 2015, 26, 90.

[18] Kim H.S., Kim K., Ryoo S.B., Seo J.H., Kim S.Y., Park J.W., et al.: “FUSION Study Group: Conventional versus nerve-sparing radical surgery for cervical cancer: a meta-analysis”. J Gynecol Oncol.,2015, 26,100.

[19] Basaran D., Dusek L., Majek O., Cibula D.: “Oncological outcomes of nerve-sparing radical hysterectomy for cervical cancer: a systematic review”. Ann. Surg. Oncol., 2015, 22, 3033.

[20] Cibula D., Sláma J., Velechovská P., Fischerova D., Zikán M., Pinkavová I., et al.: “Factors affecting spontaneous voiding recovery after radical hysterectomy”. Int. J. Gynecol. Cancer, 2010 20, 685.

[21] Liang Z., Chen Y., Xu H., Li Y., Wang D.: “Laparoscopic nerve-sparing radical hysterectomy with fascia space dissection technique for cervical cancer: description of technique and outcomes”. Gynecol. Oncol., 2010, 119, 202.

[22] Gellrich J., Hakenberg O.W., Oehlschläger S., Wirth M.P.: “Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma”. Onkologie, 2003, 26, 334.

[23] Muller M.P., Tomlinson G., Marrie T.J., Tang P., McGeer A., Low D.E., et al.: “Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?” Clin. Infect. Dis., 2005, 40, 1079.